Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 104.90% | 51.04% | -41.30% | -77.33% | -79.31% |
| Total Receivables | -48.67% | 56.65% | 123.74% | 916.65% | 1,765.39% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -65.76% | -50.78% | -64.15% | -66.28% | -23.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2,791.21% | -66.11% | -- | -69.13% | -90.05% |
| Total Current Assets | 8.73% | 49.72% | 10.05% | -14.36% | -37.90% |
|
|
|||||
| Total Current Assets | 8.73% | 49.72% | 10.05% | -14.36% | -37.90% |
| Net Property, Plant & Equipment | 8.31% | 1.10% | -58.82% | -52.57% | -53.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -7.88% | -7.72% | -7.58% | -49.85% | -55.52% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -88.04% | -87.79% |
| Total Assets | -2.03% | 0.45% | -28.78% | -47.63% | -54.51% |
|
|
|||||
| Total Accounts Payable | 0.44% | -49.36% | -7.79% | -22.30% | 17.42% |
| Total Accrued Expenses | 16.01% | 88.89% | -42.13% | -84.59% | -78.05% |
| Short-term Debt | 105.99% | 0.00% | 104.86% | 99.63% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 432.04% | 16.37% | -91.04% | -83.13% | -78.25% |
| Total Finance Division Other Current Liabilities | 4,666.77% | -99.92% | -100.00% | -98.22% | -87.15% |
| Total Other Current Liabilities | 4,666.77% | -99.92% | -100.00% | -98.22% | -87.15% |
| Total Current Liabilities | 46.29% | -12.25% | -13.75% | -54.37% | -41.69% |
|
|
|||||
| Total Current Liabilities | 46.29% | -12.25% | -13.75% | -54.37% | -41.69% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 105.99% | 0.00% | 104.86% | 99.63% | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 46.29% | -12.25% | -13.89% | -54.50% | -41.98% |
|
|
|||||
| Common Stock & APIC | 8.06% | 7.29% | 2.44% | 1.28% | -2.27% |
| Retained Earnings | -8.99% | -6.55% | -4.84% | -6.60% | -9.53% |
| Treasury Stock & Other | -34.77% | -16.33% | -31.33% | -28.96% | 12.37% |
| Total Common Equity | -13.27% | 9.80% | -29.53% | -42.32% | -56.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.27% | 9.80% | -29.53% | -42.32% | -56.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -217.65% | -955.08% | -- | -- | -- |
| Total Equity | -19.13% | 4.06% | -34.39% | -44.79% | -57.73% |
|
|
|||||